Literature DB >> 3016183

D-1 dopaminergic and beta-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM.

A J Balmforth, S G Ball, R I Freshney, D I Graham, H B McNamee, P F Vaughan.   

Abstract

Clones have been isolated from the human astrocytoma cell line G-CCM. Homogenates of clone D384 contain an adenylate cyclase that is stimulated by 3,4-dihydroxyphenylethylamine (dopamine), noradrenaline, and isoprenaline with Ka apparent values of 4, 56, and 2.7 microM, respectively. The Ka apparent value for dopamine was increased by the D-1 antagonist cis-flupenthixol, 25 and 100 nM, to 23 and 190 microM, respectively, but was unaffected by propranolol (1 microM). Noradrenaline stimulation of adenylate cyclase was only partially inhibited by either propranolol (10 microM) or cis-flupenthixol (1 microM). Propranolol (10 microM), but not cis-flupenthixol (1 microM), prevented stimulation by isoprenaline. The stimulation of adenylate cyclase by dopamine and noradrenaline remained unchanged in the presence of phentolamine (1 microM) and sulpiride (1 microM). These results suggest that clone D384 contains both D-1 dopaminergic and beta-adrenergic receptors coupled to adenylate cyclase. Dopamine stimulates D384 adenylate cyclase through D-1 receptors, isoprenaline via beta-receptors, and noradrenaline through both receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016183     DOI: 10.1111/j.1471-4159.1986.tb00670.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.

Authors:  Anthony S L Chan; Yung H Wong
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

2.  Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.

Authors:  Krista A Van Nifterik; Jaap Van den Berg; Ben J Slotman; M Vincent M Lafleur; Peter Sminia; Lukas J A Stalpers
Journal:  J Neurooncol       Date:  2011-10-26       Impact factor: 4.130

3.  Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.

Authors:  K A van Nifterik; J van den Berg; W F van der Meide; N Ameziane; L E Wedekind; R D M Steenbergen; S Leenstra; M V M Lafleur; B J Slotman; L J A Stalpers; P Sminia
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

4.  Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells.

Authors:  Irene V Bijnsdorp; Jaap van den Berg; Gitta K Kuipers; Laurine E Wedekind; Ben J Slotman; Johannes van Rijn; M Vincent M Lafleur; Peter Sminia
Journal:  J Neurooncol       Date:  2007-04-20       Impact factor: 4.130

5.  MAM-2201, One of the Most Potent-Naphthoyl Indole Derivative-Synthetic Cannabinoids, Exerts Toxic Effects on Human Cell-Based Models of Neurons and Astrocytes.

Authors:  T Coccini; U De Simone; D Lonati; G Scaravaggi; M Marti; C A Locatelli
Journal:  Neurotox Res       Date:  2021-05-04       Impact factor: 3.911

6.  Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells.

Authors:  Teresa Coccini; Luigi Manzo; Vittorio Bellotti; Uliana De Simone
Journal:  ScientificWorldJournal       Date:  2014-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.